Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147834 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
A Phase 2 study, sponsored by North Florida Foundation for Research and Education.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02147834: Clinical Trial Phase 2 study, sponsored by North Florida Foundation for Research and Education.
NCT02147834 is a Phase 2 study that was terminated before completion, run by North Florida Foundation for Research and Education. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02147834, a Phase 2 study, was terminated before completion, sponsored by North Florida Foundation for Research and Education.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
To determine if ranolazine improves angina symptoms at 4 months compared with placebo among patients who are deferred for receiving a Percutaneous Coronary Intervention (PCI) based on the Fractional Flow Reserve (FFR) measurement.
Primary Outcome
The Seattle Angina Questionnaire is a valid and reliable instrument that measures five clinically important dimensions of health in patients with coronary artery disease (physical limitation, anginal stability, anginal frequency, treatment satisfaction, and disease perception).
Interventions
- DRUG Ranolazine
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Why NCT02147834 stopped before completion
NCT02147834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Ranolazine is the first listed.
NCT02147834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02147834 about?
NCT02147834 is a clinical study titled "Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents". To determine if ranolazine improves angina symptoms at 4 months compared with placebo among patients who are deferred for receiving a Percutaneous Coronary Intervention (PCI) based on the Fractional Flow Reserve (FFR) measurement.
What is the current status of trial NCT02147834?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2015-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02147834?
The interventions under investigation include: Ranolazine (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT02147834?
This trial is sponsored by North Florida Foundation for Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02147834's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia